NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2022-10-20
DOI
10.1200/jco.22.00164
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
- (2020) David A. Reardon et al. CLINICAL CANCER RESEARCH
- Carbon Ion Beam Reirradiation in Recurrent High-Grade Glioma
- (2020) Fabian Eberle et al. Cancer Management and Research
- Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes
- (2020) Joseph A. Bovi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials
- (2019) Marijke Coomans et al. EUROPEAN JOURNAL OF CANCER
- Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
- (2019) Wolfgang Wick et al. JOURNAL OF NEURO-ONCOLOGY
- Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions
- (2018) Silvia Scoccianti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525
- (2018) Wenyin Shi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)
- (2018) Stephanie E. Combs et al. Cancer Medicine
- Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
- (2018) Farasat Kazmi et al. JOURNAL OF NEURO-ONCOLOGY
- Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)
- (2018) Pierina Navarria et al. JOURNAL OF NEURO-ONCOLOGY
- Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score
- (2018) Cathalijne C.B. Post et al. RADIOTHERAPY AND ONCOLOGY
- The evolving role for re-irradiation in the management of recurrent grade 4 glioma
- (2017) Steven P. Howard et al. JOURNAL OF NEURO-ONCOLOGY
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II trial of bevacizumab plus erlotinib for patients with recurrent malignant gliomas: Final results.
- (2017) S. Sathornsumetee et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic Radiosurgery and Bevacizumab for Recurrent Glioblastoma Multiforme
- (2017) Alvin R. Cabrera et al. Journal of the National Comprehensive Cancer Network
- Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas
- (2016) Jennifer E. Kim et al. CLINICAL CANCER RESEARCH
- Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma
- (2016) Oliver Schnell et al. JOURNAL OF NEURO-ONCOLOGY
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- Hypofractionated stereotactic radiotherapy in combination with bevacizumab or fotemustine for patients with progressive malignant gliomas
- (2015) Giuseppe Minniti et al. JOURNAL OF NEURO-ONCOLOGY
- Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma
- (2015) Kathryn M. Field et al. NEURO-ONCOLOGY
- 3D Conformal Radiotherapy and Cisplatin for Recurrent Malignant Glioma
- (2014) Lauren VanderSpek et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option
- (2014) Maya Flieger et al. JOURNAL OF NEURO-ONCOLOGY
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- Re-irradiation of recurrent glioblastoma multiforme using 11C-methionine PET/CT/MRI image fusion for hypofractionated stereotactic radiotherapy by intensity modulated radiation therapy
- (2014) Kazuhiro Miwa et al. Radiation Oncology
- Safety and Efficacy of Stereotactic Radiosurgery and Adjuvant Bevacizumab in Patients With Recurrent Malignant Gliomas
- (2011) Kyle C. Cuneo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma
- (2011) David A. Reardon et al. JOURNAL OF NEURO-ONCOLOGY
- Improvement, Clinical Course, and Quality of Life After Palliative Radiotherapy for Recurrent Glioblastoma
- (2010) Carsten Nieder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System
- (2010) Victor A. Levin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
- (2010) Shannon E. Fogh et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study
- (2010) J. J. Vredenburgh et al. ONCOLOGIST
- Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate
- (2010) Koos E. Hovinga et al. STEM CELLS
- Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
- (2009) D A Reardon et al. BRITISH JOURNAL OF CANCER
- Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas
- (2009) Philip H. Gutin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
- (2009) F. M. Iwamoto et al. NEUROLOGY
- Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: Results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy
- (2009) Stephanie E. Combs et al. RADIOTHERAPY AND ONCOLOGY
- Validation of Graded Prognostic Assessment Index for Patients With Brain Metastases: In Regard to Sperduto et al. (Int J Radiat Oncol Biol Phys 2008;70:510–514)
- (2008) Carsten Nieder et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started